Evidence map›Paper›PMID 36615882›Full record

ReviewNutrients2023

Update on Anti-Inflammatory Molecular Mechanisms Induced by Oleic Acid.

Consuelo Santa-María, Soledad López-Enríquez, Sergio Montserrat-de la Paz, Isabel Geniz, María Edith Reyes-Quiroz, Manuela Moreno, Francisca Palomares, Francisco Sobrino, Gonzalo Alba

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed, 1 pooled it
37.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 1 synthesis or guideline pooled it, 230 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Chinese herbal medicines · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. In Vitro Regeneration ofAntioxidants (Basel, Switzerland) · 2026
    Article
  17. Article
  18. Article
  19. Bioactive Potential ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Consuelo Santa-MaríaDepartamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Seville, 41012 Seville, Spain.ORCID 0000-0001-9195-2792
Soledad López-EnríquezDepartamento de Bioquímica Médica, Biología Molecular e Inmunología, Facultad de Medicina, Universidad de Seville, 41009 Seville, Spain.ORCID 0000-0003-3727-1843
Sergio Montserrat-de la PazDepartamento de Bioquímica Médica, Biología Molecular e Inmunología, Facultad de Medicina, Universidad de Seville, 41009 Seville, Spain.ORCID 0000-0001-5400-3192
Isabel GenizDistrito Sanitario Seville Norte y Aljarafe, Servicio Andaluz de Salud, 41008 Seville, Spain.
María Edith Reyes-QuirozDepartamento de Bioquímica Médica, Biología Molecular e Inmunología, Facultad de Medicina, Universidad de Seville, 41009 Seville, Spain.
Manuela MorenoDepartamento de Farmacia y Nutrición, Hospital Costa del Sol, 29603 Málaga, Spain.
Francisca PalomaresDepartamento de Bioquímica Médica, Biología Molecular e Inmunología, Facultad de Medicina, Universidad de Seville, 41009 Seville, Spain.ORCID 0000-0001-5591-7877
Francisco SobrinoDepartamento de Bioquímica Médica, Biología Molecular e Inmunología, Facultad de Medicina, Universidad de Seville, 41009 Seville, Spain.
Gonzalo AlbaDepartamento de Bioquímica Médica, Biología Molecular e Inmunología, Facultad de Medicina, Universidad de Seville, 41009 Seville, Spain.ORCID 0000-0002-6598-2039
Universidad de Sevilla · ESAndalusian Health Service · ESHospital Costa del Sol · ES

Funding

VII Plan Propio de Investigación y Transferencia, University of Seville, Spain. Grant Proyect-202200000421
6 · The paper itself

Abstract

In 2010, the Mediterranean diet was recognized by UNESCO as an Intangible Cultural Heritage of Humanity. Olive oil is the most characteristic food of this diet due to its high nutraceutical value. The positive effects of olive oil have often been attributed to its minor components; however, its oleic acid (OA) content (70-80%) is responsible for its many health properties. OA is an effective biomolecule, although the mechanism by which OA mediates beneficial physiological effects is not fully understood. OA influences cell membrane fluidity, receptors, intracellular signaling pathways, and gene expression. OA may directly regulate both the synthesis and activities of antioxidant enzymes. The anti-inflammatory effect may be related to the inhibition of proinflammatory cytokines and the activation of anti-inflammatory ones. The best-characterized mechanism highlights OA as a natural activator of sirtuin 1 (SIRT1). Oleoylethanolamide (OEA), derived from OA, is an endogenous ligand of the peroxisome proliferator-activated receptor alpha (PPARα) nuclear receptor. OEA regulates dietary fat intake and energy homeostasis and has therefore been suggested to be a potential therapeutic agent for the treatment of obesity. OEA has anti-inflammatory and antioxidant effects. The beneficial effects of olive oil may be related to the actions of OEA. New evidence suggests that oleic acid may influence epigenetic mechanisms, opening a new avenue in the exploration of therapies based on these mechanisms. OA can exert beneficial anti-inflammatory effects by regulating microRNA expression. In this review, we examine the cellular reactions and intracellular processes triggered by OA in T cells, macrophages, and neutrophils in order to better understand the immune modulation exerted by OA.

Indexed as

Diet, MediterraneanOleic AcidAnti-Inflammatory AgentsEthanolamineOleic AcidsOlive OilAnti-Inflammatory AgentsEthanolamineOleic AcidOleic Acidsoleoyl ethanolamineOlive Oilmacrophagesneutrophilsoleic acidoleoylethanolamideT cells

Identifiers

PMID36615882
PMCPMC9824542
OpenAlexW4313389018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.